Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

13.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: The anaphase promoting complex impacts repair choice by protecting ubiquitin signalling at DNA damage sites.

Nature communications·2019
Same author

The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors.

Nature communications·2019
Same author

A region-resolved mucosa proteome of the human stomach.

Nature communications·2019
Same author

Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer.

EBioMedicine·2018
Same author

A time-resolved multi-omic atlas of the developing mouse stomach.

Nature communications·2018
Same author

Author Correction: A proteomic landscape of diffuse-type gastric cancer.

Nature communications·2018

Related Experiment Video

Updated: Apr 27, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

39.4K

High throughput monoclonal antibody generation by immunizing multiple antigens.

Ying Liu1, YunDan Wang, Jing Liu

  • 1State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing, 102206, China, liuying1342@163.com.

Science China. Life Sciences
|June 22, 2014
PubMed
Summary

Generating monoclonal antibodies (mAbs) for eight proteins in one cell fusion significantly improves efficiency. This high-throughput method saves time and resources in proteomic research.

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.0K
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

18.3K

Related Experiment Videos

Last Updated: Apr 27, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

39.4K
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.0K
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

18.3K

Area of Science:

  • Biotechnology
  • Immunology
  • Proteomics

Background:

  • Monoclonal antibodies (mAbs) are vital for protein identification in proteomic research.
  • Traditional mAb generation is inefficient and time-consuming.
  • Developing high-throughput methods is crucial for advancing proteomic studies.

Purpose of the Study:

  • To establish a high-throughput, time-saving method for generating monoclonal antibodies (mAbs).
  • To assess the feasibility of producing mAbs against multiple antigens simultaneously in a single cell fusion.
  • To compare the efficacy of liquid and semi-solid media in hybridoma generation.

Main Methods:

  • Selected eight key human proteins as antigens.
  • Mixed antigens were administered to a single mouse for immunization over 10 days.
  • Hybridomas were generated through a single cell fusion.
  • Enzyme-linked immunosorbent assay (ELISA) and Western blotting were used for screening and validation.
  • Hybridoma generation in liquid versus semi-solid media was evaluated.

Main Results:

  • Antibodies against all eight immunogens were successfully induced in the mouse.
  • Hybridomas specific to all eight proteins were obtained after a single cell fusion.
  • Western blotting confirmed specific positive results for hybridomas against five out of the eight proteins.
  • Differences in antigen reactivity were observed between hybridomas cultured in liquid and semi-solid media.

Conclusions:

  • A high-throughput method for generating monoclonal antibodies (mAbs) against multiple proteins in one cell fusion was successfully established.
  • This approach significantly increases the efficiency and reduces the time required for mAb production.
  • The findings offer alternative strategies to enhance the efficacy of mAb generation for proteomic research.